Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -777.60K | -840.80K | -5.40K | 613.10K | 1.31M |
| Total Depreciation and Amortization | 181.20K | 179.60K | 183.40K | 188.30K | 194.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -198.30K | -378.30K | -339.80K | -405.60K | -275.00K |
| Change in Net Operating Assets | 228.00K | 702.80K | 1.45M | 1.35M | 661.50K |
| Cash from Operations | -566.70K | -336.70K | 1.29M | 1.74M | 1.89M |
| Capital Expenditure | -159.70K | -1.10K | 800.00 | 0.00 | -7.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.20M | 5.80M | -4.07M | -777.80K | -4.21M |
| Cash from Investing | -1.36M | 5.79M | -4.07M | -777.80K | -4.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -11.20K | -12.00K | -15.40K | -41.60K | -34.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.72M | -1.72M | -1.72M | -1.72M | -1.72M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.73M | -1.73M | -1.74M | -1.77M | -1.76M |
| Foreign Exchange rate Adjustments | -17.70K | -73.10K | -68.50K | -9.60K | 68.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.68M | 3.65M | -4.59M | -811.70K | -4.02M |
